| |
| |
|
| Insider
Information: |
Granadillo Pedro P |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
258,751 |
|
|
Indirect Shares
|
118,154 |
|
|
| Direct
Value |
$91,866,318 |
|
|
|
Indirect Value
|
$83,429,918 |
|
|
| Total
Shares |
376,905 |
|
|
| Total
Value |
$175,296,237 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
First Indiana Corp |
FINB |
Director |
2008-01-02 |
0 |
2004-01-02 |
0 |
Premium* |
|
|
Haemonetics Corp |
HAE |
Director |
2018-11-08 |
15,335 |
2005-09-02 |
0 |
Premium* |
|
|
Capricor Therapeutics |
CAPR |
Director |
2007-10-16 |
27,588 |
|
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
Senior Vice President |
2004-09-23 |
106,316 |
2004-09-23 |
98,154 |
Premium* |
|
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
87,251 |
2009-10-07 |
0 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
Director |
2015-02-21 |
0 |
2013-02-07 |
0 |
Premium* |
|
|
Immunovant Inc |
IMVT |
Director |
|
0 |
2019-05-09 |
20,000 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HAE |
Haemonetics Corp |
Director |
– • – |
2012-08-13 |
4 |
OE |
$44.74 |
$268,440 |
D/D |
6,000 |
12,626 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2015-02-21 |
4 |
D |
$46.00 |
$1,398,998 |
D/D |
(30,413) |
0 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2005-11-02 |
4 |
B |
$48.86 |
$146,588 |
D/D |
3,000 |
4,000 |
2.39 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2008-05-05 |
4 |
B |
$53.59 |
$96,462 |
D/D |
1,800 |
6,087 |
2.39 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2017-12-01 |
4 |
S |
$57.00 |
$406,184 |
D/D |
(7,118) |
32,381 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2010-11-05 |
4 |
S |
$57.72 |
$346,300 |
D/D |
(6,000) |
5,501 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2008-11-05 |
4 |
B |
$57.95 |
$202,829 |
D/D |
3,500 |
9,941 |
2.39 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2011-08-15 |
4 |
S |
$59.74 |
$50,779 |
D/D |
(850) |
5,595 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2012-08-13 |
4 |
S |
$70.05 |
$420,310 |
D/D |
(6,000) |
6,626 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2012-11-12 |
4 |
S |
$80.40 |
$1,286,341 |
D/D |
(16,000) |
6,626 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2018-09-17 |
4 |
AS |
$108.92 |
$3,446,909 |
D/D |
(30,824) |
27,657 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2018-11-08 |
4 |
S |
$114.50 |
$1,410,869 |
D/D |
(12,322) |
15,335 |
0 |
- |
|
62 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
